Tango Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TNGX research report →
About the company
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5).
- CEO
- Malte Peters
- IPO
- 2020
- Employees
- 155
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $3.67B
- P/E
- -35.49
- P/S
- 64.32
- P/B
- 10.80
- EV/EBITDA
- -33.68
- Div Yield
- 0.00%
- Gross Margin
- 97.25%
- Op Margin
- -206.22%
- Net Margin
- -188.15%
- ROE
- -41.54%
- ROIC
- -27.69%
- Revenue
- $62.38M · 48.29%
- Net Income
- $-101,594,000 · 22.03%
- EPS
- $-0.87 · 26.89%
- Op Income
- $-111,289,000
- FCF YoY
- -5.81%
- 52W High
- $34.39
- 52W Low
- $5.34
- 50D MA
- $25.41
- 200D MA
- $15.39
- Beta
- 1.13
- Avg Volume
- 4.19M
Get TickerSpark's AI analysis on TNGX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Crystal Adam | other | 27,000 |
| Jul 1, 26 | Crystal Adam | other | 27,000 |
| Jul 1, 26 | Crystal Adam | sell | 19,629 |
| Jul 1, 26 | Crystal Adam | sell | 7,371 |
| Jun 19, 26 | Azelby Robert | other | 35,910 |
| Jun 19, 26 | Azelby Robert | other | 5,740 |
| Jun 19, 26 | Azelby Robert | other | 0 |
| Jun 5, 26 | Ketchum John B | other | 25,000 |
| Jun 5, 26 | Ketchum John B | other | 4,000 |
| Jun 5, 26 | Calhoun Lesley Ann | other | 25,000 |
Our TNGX coverage
Recent articles, reports, and earnings notes.
No research on TNGX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TNGX report →Similar companies
Peers in the same neighborhood.